Wholesale Peptides Philippines: Bulk Guide

Type "peptide wholesale price list philippines" into a search bar and you will find retail catalogues, Shopee and Lazada reseller listings, and a couple of telehealth operations such as Seenergie that gate price behind a consultation. What you will not find is a table of quantity breaks. The one publicly published business offer anyone in this market has committed to a page is Noki Labs and their CLINIC15 code, 15% off orders over PHP 10,000, stated on their Manila and Cebu city pages.

It is tempting to read that absence as evasion. It is worth understanding the two commercial reasons behind it first, because both of them affect how you should negotiate.

A published tier is a target. A seller who holds no stock carries no inventory cost, no cold-chain overhead and no capital tied up in vials sitting in a fridge in Metro Manila. That seller can read your published tier, undercut it by a small margin, take the order, and only then place it upstream with your customer money. Publishing a number hands the least-committed operators in the market a floor to shoot at, and the buyer who chases it usually ends up waiting three weeks for a parcel.

A tier written for the average buyer fits nobody. The real per-vial number moves on compound mix, order cadence, whether you take one dispatch or a standing monthly draw, whether you want plain outer packaging or your own label, and whether you need an invoice. Twelve vials of GHK-Cu and twelve vials of retatrutide are different amounts of money and different amounts of risk to hold. A single printed grid either overprices the small mixed order or underprices the large single-SKU one, and in practice it does both.

You cannot evaluate a bulk quote without a retail anchor, and the useful anchor is a published Philippine catalogue in pesos rather than a converted overseas figure. Below is the per-vial retail pricing our partner and supplier Primara Labs lists. Bulk sits below this. How far below is the thing that gets quoted, not printed.

The right-hand column is a retail discounted price, not a bulk tier. Primara publishes no wholesale tiers, no minimum order and no percentages of any kind. Business pricing is quoted per WhatsApp enquiry. Treat the retail column as your ceiling and work down from it with a real quantity in hand.

Note the spread across the catalogue. GHK-Cu at ₱1,325 and retatrutide at ₱3,325 are not the same procurement problem, and a supplier who quotes you the same discount shape across both is quoting a policy rather than reading their own stock position. Line-by-line pricing against your actual mix is the signal you are looking for. The wider market context sits in the PH peptide price index.

Most bulk buyers frame this as a unit price question. It is a cash cycle question, and the unit price is the smallest of the three variables in it.

Importing means your money leaves the account on day zero and your goods arrive somewhere between a week and a month later, assuming nothing is detained. Buying local stock means money leaves the account and the vials are in your fridge the same afternoon. On the same capital, the second model turns more times per year. Two turns at a thinner margin beats one turn at a fatter one more often than people expect, and it does so without requiring you to predict demand a month out.

The arithmetic above is illustrative. The point it makes is not. Before you take an import quote, price three things rather than one: the per-vial saving, the cost of the extra idle capital across a year of cycles, and the expected value of the shipment that does not arrive. Most first-time bulk buyers price the first and quietly assume the other two are zero.

There is a hybrid worth naming. Hold a working buffer locally for anything with a committed schedule against it, and use import cycles only for slow movers where a three-week wait costs you nothing. That splits the difference honestly instead of pretending one model wins everywhere.

Research peptides are not scheduled substances under Philippine law, and imported as research material at personal-use volumes they are generally tolerated by the Bureau of Customs. That tolerance is about character, not a published number. What changes as volume climbs is how the parcel reads: identical vials in quantity, repeat consignments to the same address, or a declared value that no individual would plausibly self-fund for personal use.

Once a parcel reads commercial, the questions change with it. Who is the importer of record. Is the declared valuation defensible. Are these registered products, which for research peptides they are not. Unregistered injectables can be detained at NAIA inspection, and detention is less an appeal process than a waiting game your cold packs are guaranteed to lose. The regulatory frame is set out in the FDA Philippines regulation filing and the legality filing.

That second option is the one most Philippine bulk buyers land on, for a simple structural reason: a domestic transaction has no customs leg at all. The variable is not managed, it is absent.

One vial is a fridge shelf. Thirty vials is inventory, and inventory needs a written rule rather than a habit. The change is not that the science gets harder. It is that a single unnoticed failure now writes off a five-figure position instead of one vial.

Five things worth putting in place before your first bulk parcel arrives. First, a dedicated fridge, not the staff fridge that gets opened forty times a day and holds someone lunch. Second, a min/max recording thermometer, which costs almost nothing and is the only way to know whether an excursion happened while nobody was watching. Third, a brownout plan: a Metro Manila condo or clinic fridge that loses power overnight is a genuine cold-chain break, and there is no test you can run afterwards to reassure yourself. Fourth, batch numbers logged against a received date on arrival, so that a problem can be quarantined to one batch instead of your whole holding. Fifth, first in first out, written down, because at thirty vials nobody remembers which box came when.

The receiving window is where most breaks actually happen. An insulated bulk parcel that sits in a building reception for four hours has had a worse afternoon than the entire courier leg. Nominate a person to receive it, and give the supplier that person name and number rather than a generic front desk.

Every supplier in this market says they can supply. Roughly half of them mean they can order it. The distinction is invisible in a catalogue and obvious the moment you apply pressure, so apply it before you commit money rather than after.

The test: ask for a same-day delivery on a named SKU, on a weekday morning, inside Metro Manila. Not a quote. A delivery. A supplier who holds local stock gives you one of two clean answers. Either yes, with a confirmation cut-off time attached, or no, that SKU is out, and here is the restock date. Both answers are useful, and both are only available to someone who can see their own fridge.

A drop-shipper cannot produce either answer, and the substitutes are consistent enough to be diagnostic. You get "let me check with the lab". You get a batch that lands soon. You get a two to three week window that never shortens no matter how many times you ask. Frequently you get a discount offered unprompted, because the only thing they can adjust is price, and the discount is really compensation for a wait they have not yet admitted to.

Neither model is illegitimate. Drop-shipping is a perfectly reasonable way to serve a hobbyist buying one vial a quarter who does not care whether it takes three weeks. It is a bad fit for anyone with a schedule to keep, because the lead time is not yours and neither is the cold chain. If you are buying to resell or to hold against bookings, the question is not who is cheapest. It is who can be wrong about demand and still deliver on Thursday.

This is the question that separates buying for a business from buying for yourself, and it is the one most often raised too late. If the purchase has to appear in your books as a supported expense, you need an official sales invoice from a BIR-registered seller, issued in your registered business name, with a line description you are comfortable defending. If you are VAT registered, that document is also what supports input VAT. Without it the cost either sits outside your books entirely or sits inside them with nothing behind it, and the second is worse than the first.

A large part of this market operates informally over chat. For an individual buyer that is unremarkable. For a company, a clinic or a reseller it is a structural problem that does not resolve itself. Four questions, asked in your first message rather than after delivery:

• Are you BIR registered, and can you issue an official sales invoice.
• In what name will the invoice be issued, and can it carry my TIN.
• How will the goods be described on the invoice line, and is that description one I can live with in my own records.
• What payment channels do you accept, and does the receiving account match the invoicing entity.

That last point does more work than it looks like it does. A supplier who can only take payment into a personal e-wallet and cannot issue anything is not necessarily dishonest, but they are telling you plainly what kind of counterparty they are set up to be. Decide whether that fits your books before you have thirty vials of their stock and a reconciliation problem.

Primara ordering runs over WhatsApp with no checkout and no forms, so invoicing arrangements are part of the enquiry conversation rather than something a cart decides for you. Raise it in your first message.

Because pricing in this market is quoted rather than published, the quality of your enquiry determines how long it takes to get a figure. A vague message buys you three rounds of clarifying questions and a week. A specific message usually returns a number the same day, because you have removed every reason for the supplier to ask you something first.

Seven things to include, in roughly this order:

• Who you are and what the volume is for, in one line.
• Exact SKUs and vial sizes. "Retatrutide 10mg", not "retatrutide".
• Quantity per SKU. A real number, not a range you intend to negotiate.
• Whether this is a one-time order or recurring, and at what cadence if recurring.
• Delivery city and district, and whether you need same-day.
• Invoicing requirement, stated up front rather than discovered at delivery.
• Packaging requirement: plain outer packaging, or your own label, and your decision timeline.

A good reply gives you a per-vial figure against each stated SKU at your stated quantity, a dispatch date, and a straight answer on invoicing. A poor reply asks what your budget is, or returns a price band with no quantity attached to it. The first is a supplier reading their stock. The second is a supplier reading you.

Clinic supply is a different conversation with different constraints, covered in the clinic sourcing guide. Own-label supply sits on the private label page.